Healthcare - Biotechnology - NASDAQ - US
$ 0.253
-38.3 %
$ 451 K
Market Cap
-0.02
P/E
INCOME STATEMENT
0
REVENUE
-29.2 M
OPERATING INCOME
-32.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
NexImmune, Inc.
| Revenue | 0 |
| Cost Of Revenue | 1.02 M |
| Gross Profit | -1.02 M |
| Operating Expenses | 28.2 M |
| Operating Income | -29.2 M |
| Other Expenses | 3.15 M |
| Net Income | -32.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.0 | 1.5 | 0.9 | 0.6 | 0.4 | 0.2 |
| Gross Profit | (1.0) | (1.5) | (0.9) | (0.6) | (0.4) | (0.2) |
| OPERATING INCOME | ||||||
| Operating Expenses | 28.2 | 63.1 | 53.3 | 27.9 | 20.9 | 13.2 |
| Selling, General and Administrative Expenses | 9.9 | 15.9 | 15.8 | 10.0 | 5.7 | 5.2 |
| Research and Development Expenses | 18.3 | 47.1 | 37.5 | 17.8 | 15.2 | 8.0 |
| Operating Income | (29.2) | (63.1) | (53.3) | (27.9) | (20.9) | (13.2) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | (576.7) | 0.9 | 1.7 | 0 | 0 |
| Total Other Income | (3.2) | 0.6 | 2.4 | (2.0) | 0.3 | 0.4 |
| Pre-Tax Income | (32.3) | (62.5) | (50.9) | (29.9) | (20.5) | (12.8) |
| NET INCOME | ||||||
| Tax Provision | 2 | (576.7) | 0.8 | 1.8 | (0.2) | 0.4 |
| Net Income | (32.3) | 514.2 | (51.7) | (31.6) | (20.3) | (12.8) |
| EPS | 30.8 | 534 | 56.7 | 34.8 | 22.5 | 14.2 |